NCT04772989CompletedPhase 1
A study to Evaluate AB308 in Combination with AB122 in Participants with Advanced Malignancies (ARC-12)
Source: EU CTIS (euclinicaltrials.eu) · Last updated 6 Mar 2025
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 18 (actual)
- First submitted
- 2 Apr 2024
- Start date
- 13 Dec 2022
- Lead sponsor
- Arcus Biosciences Inc.
- Diseases
- Diffuse large B-cell lymphoma, Hodgkin lymphoma, Melanoma, Cervical cancer, Lung cancer, Gastric and esophageal cancer, Multiple myeloma
- NCT number
- NCT04772989
- EU CT number
- 2024-511116-25-00
- EudraCT number
- 2021-005589-16
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 18
- 7 sites in 2 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.
Sites (7)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Fir Huvh Fundacio Institut De Recerca Hospital Universitari Vall De Hebron Coordinator of this site? Confirm its status | Barcelona | Spain | Completed |
| Hospital Universitario 12 de Octubre Coordinator of this site? Confirm its status | Madrid | Spain | Completed |
| Clinica Universidad de Navarra Coordinator of this site? Confirm its status | Madrid | Spain | Completed |
| Hospital Universitario Fundación Jiménez Díaz Coordinator of this site? Confirm its status | Madrid | Spain | Completed |
| Clínica Universidad de navarra Coordinator of this site? Confirm its status | Pamplona | Spain | Completed |
| Hlk Sp. z o.o. Coordinator of this site? Confirm its status | Lublin | Poland | Completed |
| Med Polonia Sp z o.o. Coordinator of this site? Confirm its status | Poznan | Poland | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.